Showing 1 to 3 of 3 results


AstraZeneca Weighs US Stock Market Listing, Threatening London's Status
AstraZeneca, the UK's largest listed firm, is considering moving its stock market listing to the US due to frustrations with UK regulations and pricing disputes, potentially causing significant damage to the London Stock Exchange.
AstraZeneca Weighs US Stock Market Listing, Threatening London's Status
AstraZeneca, the UK's largest listed firm, is considering moving its stock market listing to the US due to frustrations with UK regulations and pricing disputes, potentially causing significant damage to the London Stock Exchange.
Progress
56% Bias Score


Shell to Appeal 'Unlawful' Jackdaw Gas Project Ruling
A Scottish court ruled Shell's Jackdaw gas field project unlawful due to insufficient indirect emissions consideration, prompting Shell's CEO to appeal to the UK Supreme Court and consider moving its stock market listing from London to New York.
Shell to Appeal 'Unlawful' Jackdaw Gas Project Ruling
A Scottish court ruled Shell's Jackdaw gas field project unlawful due to insufficient indirect emissions consideration, prompting Shell's CEO to appeal to the UK Supreme Court and consider moving its stock market listing from London to New York.
Progress
56% Bias Score

AstraZeneca Weighs US Relocation Amid UK Disputes
AstraZeneca, facing disagreements with UK authorities over drug pricing and support, is considering moving its stock market listing and potentially its headquarters to the US, jeopardizing Britain's industrial strategy and London's financial standing.

AstraZeneca Weighs US Relocation Amid UK Disputes
AstraZeneca, facing disagreements with UK authorities over drug pricing and support, is considering moving its stock market listing and potentially its headquarters to the US, jeopardizing Britain's industrial strategy and London's financial standing.
Progress
56% Bias Score
Showing 1 to 3 of 3 results